633 related articles for article (PubMed ID: 6241752)
21. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
Coller BS
J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
[TBL] [Abstract][Full Text] [Related]
22. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor.
Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE
Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601
[TBL] [Abstract][Full Text] [Related]
23. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
[TBL] [Abstract][Full Text] [Related]
24. Von Willebrand factor-dependent agglutination of washed fixed human platelets by insoluble collagen isolated from bovine aorta.
Perret BA; Furlan M; Jenö P; Beck EA
J Lab Clin Med; 1986 Mar; 107(3):244-52. PubMed ID: 3005453
[TBL] [Abstract][Full Text] [Related]
25. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
26. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
Mills DC; Hunchak K; Karl DW; Kirby EP
Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
[TBL] [Abstract][Full Text] [Related]
27. Abnormality of glycoprotein Ib in two cases of "pseudo"-von Willebrand's disease.
Bryckaert MC; Pietu G; Ruan C; Tobelem G; Girma JP; Meyer D; Larrieu MJ; Caen JP
J Lab Clin Med; 1985 Oct; 106(4):393-400. PubMed ID: 2931492
[TBL] [Abstract][Full Text] [Related]
28. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
[TBL] [Abstract][Full Text] [Related]
29. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
Green D; Potter EV
J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of ristocetin-induced platelet agglutination by vancomycin.
Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA
Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760
[TBL] [Abstract][Full Text] [Related]
31. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
32. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
[TBL] [Abstract][Full Text] [Related]
34. Variant forms of von Willebrand's disease: type IIA, type IIB and platelet-type von Willebrand's disease.
Takahashi H
Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1678-89. PubMed ID: 6335811
[No Abstract] [Full Text] [Related]
35. [Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].
Guermazi S; Conard J; Samama MM; Dellagi K
Pathol Biol (Paris); 2006 Apr; 54(3):159-65. PubMed ID: 16176858
[TBL] [Abstract][Full Text] [Related]
36. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
[TBL] [Abstract][Full Text] [Related]
37. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
McPherson J; Soberano ME; Macdonald C; Zucker MB
Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
[TBL] [Abstract][Full Text] [Related]
38. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
Allain JP; Cooper HA; Wagner RH; Brinkhous KM
J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
[TBL] [Abstract][Full Text] [Related]
39. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
[TBL] [Abstract][Full Text] [Related]
40. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]